Røsjø, H. ., Husberg, C. ., Dahl, M. ., Stridsberg, M. ., Sjaastad, I. ., Finsen, A. ., … Christensen, G. . (2010). Chromogranin B in heart failure: a putative cardiac biomarker expressed in the failing myocardium. Circulation. Heart Failure, 3(4), 503-11. https://doi.org/10.1161/CIRCHEARTFAILURE.109.867747

Ottesen, A. ., Louch, W. ., Carlson, C. ., Landsverk, O. ., Kurola, J. ., Johansen, R. ., … Røsjø, H. . (2015). Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling. Journal of the American College of Cardiology, 65(4), 339-351. https://doi.org/10.1016/j.jacc.2014.10.065 (Original work published 2015)

Ottesen, A. ., Carlson, C. ., Louch, W. ., Dahl, M. ., Sandbu, R. ., Johansen, R. ., … Røsjø, H. . (2017). Glycosylated Chromogranin A in Heart Failure: Implications for Processing and Cardiomyocyte Calcium Homeostasis. Circulation. Heart Failure, 10(2). https://doi.org/10.1161/CIRCHEARTFAILURE.116.003675

Ottesen, A. ., Carlson, C. ., Eken, O. ., Sadredini, M. ., Myhre, P. ., Shen, X. ., … Louch, W. . (2019). Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca²⁺-Dependent Arrhythmia. Circulation. Arrhythmia and Electrophysiology, 12(4), e007045. https://doi.org/10.1161/CIRCEP.118.007045